Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,280 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07843485RecruitingPhase 3
Weight loss medication for adults with type 2 diabetes
This study tests a new medicine called petrelintide to help people with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be an option if you've struggled with weight loss through diet alone.
Los Angeles, CaliforniaAges 18 years+ - NCT07843498RecruitingPhase 3
Testing a new weight-loss medicine in adults with overweight or obesity
This study tests a new medication called petrelintide to see how well it helps people lose weight and improve their health. It's for adults with overweight or obesity who have struggled to lose weight with diet alone.
Anniston, AlabamaAges 18 years+ - NCT07844616Recruiting
Eggs, gut health, and metabolism study
This study looks at how eating whole eggs versus egg whites affects your gut bacteria, metabolism, and immune system. It aims to understand how eggs may influence health markers in people of different weight ranges.
Storrs, ConnecticutAges 18–50 - NCT07836452RecruitingPhase 1
Study of a new drug for healthy people and those with Stargardt disease
This study tests a new drug called CITY-RBP4 in healthy volunteers and in people with Stargardt disease (STGD1), a genetic condition that causes vision loss. The goal is to see if the drug is safe and how it affects the body, which may help guide future treatments for Stargardt disease.
Melbourne, VictoriaAges 12–45 - NCT07838220RecruitingPhase 1
Study of IBI3016 in Japanese adults with high blood pressure
This trial tests an experimental drug called IBI3016 for lowering high blood pressure. It is specifically for Japanese adults who have high blood pressure while currently on treatment.
OsakaAges 18–75 - NCT07840612RecruitingPhase 1
How probenecid affects mirdametinib in healthy volunteers
This study checks how probenecid (a medicine for gout) changes the levels of mirdametinib (an experimental cancer drug) in healthy people. It helps doctors understand dosing and safety before testing in patients.
Neu-UlmAges 18–65 - NCT07835633RecruitingPhase 1
Safety study of a single injection of ACC085 in healthy adults
This trial tests a new medication called ACC085 given as a single injection to healthy adults. The goal is to find out how safe it is and how the body processes it.
Wuhan, HubeiAges 18–55 - NCT07840326RecruitingPhase 2
Study of SUN-627 for progressive multiple sclerosis
This study tests an experimental medicine called SUN-627 for people with progressive multiple sclerosis (MS) that is not currently flaring up. The goal is to see if it can slow down worsening disability without causing serious side effects.
Atlanta, GeorgiaAges 18–70 - NCT07837778Recruiting
Balance and posture study for healthy adults
This study looks at how anchoring (a technique using hand contact) affects balance and posture in healthy adults. It may help improve balance training or rehabilitation programs.
Orlando, FloridaAges 18–50 - NCT07840092Recruiting
Blood and tissue markers for liver cancer treatment response
This study looks at blood and tissue samples from people with liver cancer to find markers that can predict how well treatment works and whether the cancer might come back. It may help doctors personalize treatment and follow-up care.
TianjinAges 18 years+ - NCT07832292RecruitingPhase 2
Study of an investigational drug for metastatic prostate cancer
This trial tests an experimental drug (JNJ-101556143) for men with metastatic prostate cancer that has stopped responding to hormone therapy. The goal is to see if this drug can slow down or stop the cancer from growing.
Lafayette, LouisianaAges 18 years+ - NCT07828392Recruiting
Calf tightness and foot touch sensitivity study
This study looks at how calf muscle tightness relates to foot sensitivity. It may help understand the link between muscle tightness and touch sensations in the feet.
NiğdeAges 18–65 - NCT07824271RecruitingPhase 1
Testing the safety of ALZ-507 in healthy older adults
This study tests a new oral drug called ALZ-507, which is being developed for Alzheimer's disease. It is an early-phase trial to check the drug's safety and how it is processed in the body, in healthy older adults.
Miami, FloridaAges 50–75 - NCT07823205RecruitingPhase 1
Oral KT-621 study for healthy volunteers
This trial tests a new oral medication, KT-621, given as different tablet or capsule forms. It helps researchers understand how the body handles the drug, which is the first step toward future treatments.
Lincoln, NebraskaAges 18–55 - NCT07818967RecruitingPhase 1
A study of abemaciclib in healthy volunteers
This study tests how a medicine called abemaciclib is processed by the body in healthy people. It helps researchers understand the drug's effects and safety before it is used in patients.
SingaporeAges 21 years+ - NCT07819097RecruitingPhase 3
RSV vaccine study for healthy older adults
This study tests an RSV vaccine to see if it is safe and helps your immune system fight the virus. It's for older adults who are generally healthy, and it may help protect you from severe RSV illness.
Scottsdale, ArizonaAges 60 years+ - NCT07822919RecruitingPhase 1
Study of AWT020 for advanced solid tumors
This trial tests an investigational drug called AWT020 for people with advanced solid tumors that have grown after standard treatment. The goal is to see if AWT020 can help shrink or control the cancer, and it might be an option for you if other treatments haven't worked or aren't suitable.
Plantation, FloridaAges 18 years+ - NCT07817875RecruitingPhase 3
Tirzepatide for weight loss in children aged 6 to under 12
This study tests a once-weekly medication called tirzepatide to help children aged 6 to under 12 with obesity lose weight. It compares the medication to a placebo (inactive shot) to see if it safely helps with weight loss in this age group.
Tucson, ArizonaAges 6–11 - NCT07820085RecruitingPhase 2/Phase 3
Oral treatment for light sensitivity in EPP and XLP
This study tests an oral medication, PORT-77, to reduce pain and sensitivity to sunlight in people with EPP or XLP. It may help those who experience symptoms shortly after sun exposure.
Huntington Beach, CaliforniaAges 12 years+ - NCT07819136RecruitingPhase 1/Phase 2
REC-7735 for people with advanced solid tumors
This study tests a new drug called REC-7735 for people with solid tumors that have a specific genetic change (PIK3CA H1047R). The drug targets this change to try to stop the cancer from growing.
Grand Rapids, MichiganAges 18 years+ - NCT07821658Recruiting
Lecanemab treatment study for Alzheimer's disease
This study looks at people who are taking or have taken lecanemab (a medication for Alzheimer's disease). It aims to gather more information about the treatment's effects in real-world settings.
Nutley, New JerseyAges Any age - NCT07822529Recruiting
Long-term study of Tremfya for inflammatory bowel disease
This study follows adults with moderate-to-severe Crohn's disease or ulcerative colitis who are starting treatment with guselkumab (Tremfya). It aims to see how well the medication works and how long the effects last over time.
AmiensAges 18 years+ - NCT07811908RecruitingPhase 2
Testing a new malaria treatment for children
This study tests a new malaria treatment for children with mild (uncomplicated) malaria. The goal is to see if the treatment safely and effectively clears the infection.
BanforaAges 2–12 - NCT07809815RecruitingPhase 1
Drug interaction study of befotertinib in healthy volunteers
This study checks how befotertinib, an experimental cancer drug, interacts with other drugs in healthy people. It helps make sure the drug is safe and works well when taken with other medicines.
Hangzhou, ZhejiangAges 18–45
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,280 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.